Develop New Vaccines, Therapeutic Proteins and Enzyme Products at the Health Protection Agency's Biopharmaceutical Production Unit

Taking an original concept from the bench through to the production of GMP biopharmaceutical material for clinical trials is challenging. The world class expertise of the Health Protection Agency's centre at Porton Down in process development, scale-up and GMP manufacture can assist biotechnology companies to develop new vaccines, therapeutic proteins and enzyme products for today's market.

Download this free whitepaper to find out more.